Newsletter

September 2019 Scorecard

The September 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Stifel Financial Acquires B&F Capital Markets

Stifel Financial Corp. (SF) announced on September 3 that the company completed its acquisition of B&F Capital Markets, Inc. B&F is a leader in providing small regional and community banks with extensive interest rate swap capabilities. Stifel is a financial services holding company headquartered in St. Louis.   Sonal sent an alert to subscribers at […]

Read more...

August 2019 Scorecard

The August 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Phototronics’ Board of Directors Authorizes Share Repurchase Program

Phototronics, Inc. (PLAB) announced on August 28 that its Board of Directors authorized a stock repurchase program. The company had paused its share repurchase activity earlier in the year to focus on its investment activities. Under this program, Phototronics may repurchase up to $100 million in common stock.   Sonal sent an alert to subscribers […]

Read more...

AbbVie Receives FDA Approval for RINVOQ

On August 16, AbbVie (ABBV) announced that it received FDA approval of RINVOQ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor. The drug is expected to be available in the U.S. by the end of August 2019. RINVOQ treats adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate […]

Read more...